Vegenics Licenses VEGF-C Development Rights From HGS Spinoff CoGenesys

Vegenics is in “leading position” in developing VEGF-C antagonists, firm says.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet